Clinical Trials Browser

Phase 2 × Neoplasms, Germ Cell and Embryonal × olaparib × Clear all

NCT02533765 2025-01-30

Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal